The motion: Prevention of prostate cancer with a 5α-reductase inhibitor is feasible

Claus Roehrborn, Yair Lotan, Andrea Tubaro, Cosimo De Nunzio, C. G. Roehrborn, Y. Lotan, A. Tubaro, C. De Nunzio

Research output: Contribution to journalComment/debate

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)396-400
Number of pages5
JournalEuropean urology
Volume49
Issue number2
DOIs
StatePublished - Jan 1 2006

ASJC Scopus subject areas

  • Urology

Cite this

Roehrborn, C., Lotan, Y., Tubaro, A., De Nunzio, C., Roehrborn, C. G., Lotan, Y., Tubaro, A., & De Nunzio, C. (2006). The motion: Prevention of prostate cancer with a 5α-reductase inhibitor is feasible. European urology, 49(2), 396-400. https://doi.org/10.1016/j.eururo.2005.12.013